BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11499744)

  • 1. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance.
    Walker HA; McGing E; Fisher I; Böger RH; Bode-Böger SM; Jackson G; Ritter JM; Chowienczyk PJ
    J Am Coll Cardiol; 2001 Aug; 38(2):499-505. PubMed ID: 11499744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes.
    Darko D; Dornhorst A; Kelly FJ; Ritter JM; Chowienczyk PJ
    Clin Sci (Lond); 2002 Oct; 103(4):339-44. PubMed ID: 12241530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.
    Quyyumi AA
    J Am Coll Cardiol; 1998 Oct; 32(4):904-11. PubMed ID: 9768710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
    Piatti P; Fragasso G; Monti LD; Setola E; Lucotti P; Fermo I; Paroni R; Galluccio E; Pozza G; Chierchia S; Margonato A
    Circulation; 2003 Jan; 107(3):429-36. PubMed ID: 12551867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
    J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease.
    Chowienczyk PJ; Kneale BJ; Brett SE; Paganga G; Jenkins BS; Ritter JM
    Clin Sci (Lond); 1998 Feb; 94(2):129-34. PubMed ID: 9536920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.
    Hambrecht R; Hilbrich L; Erbs S; Gielen S; Fiehn E; Schoene N; Schuler G
    J Am Coll Cardiol; 2000 Mar; 35(3):706-13. PubMed ID: 10716474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans.
    Hirooka Y; Egashira K; Imaizumi T; Tagawa T; Kai H; Sugimachi M; Takeshita A
    J Am Coll Cardiol; 1994 Oct; 24(4):948-55. PubMed ID: 7930229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.
    Mercuro G; Zoncu S; Saiu F; Sarais C; Rosano GM
    Am J Cardiol; 2002 Oct; 90(7):747-50. PubMed ID: 12356389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral L-arginine improves endothelial function in healthy individuals older than 70 years.
    Bode-Böger SM; Muke J; Surdacki A; Brabant G; Böger RH; Frölich JC
    Vasc Med; 2003 May; 8(2):77-81. PubMed ID: 14518608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
    Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
    Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure.
    Bennett-Richards KJ; Kattenhorn M; Donald AE; Oakley GR; Varghese Z; Bruckdorfer KR; Deanfield JE; Rees L
    Kidney Int; 2002 Oct; 62(4):1372-8. PubMed ID: 12234308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.
    Mittermayer F; Schaller G; Pleiner J; Krzyzanowska K; Kapiotis S; Roden M; Wolzt M
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2574-80. PubMed ID: 17473072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
    Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
    Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.